The Risk of Quiet Portfolios: ESG Blind Spots in Private Markets

Eureden is a large farmer‑owned French agri‑food co‑operative headquartered in Brittany, combining upstream...

There’s no denying that ESG risk exposure in the pharmaceutical industry is high. This stems from the intense...

As 2026 kicks off, I want to take a moment to reflect on the year we’ve just closed. 2025 was an important year for...

The biotech industry faces significant ESG risks, particularly in governance. Social and operational risks are less...

Human rights concerns took center stage in November, with rising scrutiny on how digital platforms and luxury brands...

When Meta's market value declined by $307 billion over four trading days in October 2025, it demonstrated a fundamental...

SESAMm’s AI-generated ESG Assessment Reports deliver fast, sharp insights into the ESG performance, risks, and...

The ESG landscape for U.S. private equity firms is increasingly defined by systemic governance pressure and rising...

In a recent interview, CEO Sylvain Forté spoke with Fintech Global about how the SESAMm has evolved, the role of AI in...